2019
DOI: 10.1016/j.nut.2018.05.020
|View full text |Cite
|
Sign up to set email alerts
|

Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
83
0
3

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1
1

Relationship

2
8

Authors

Journals

citations
Cited by 115 publications
(88 citation statements)
references
References 41 publications
2
83
0
3
Order By: Relevance
“…Interestingly, in a single-dose (100 mg) study on older participants (>60 years), Evans et al [19] reported more distinct differences between the bioavailabilities of ubiquinol and ubiquinone formulations; however, they did not test water-soluble CoQ10 formulations. On the other hand, López-Lluch et al have recently reported the results of their single-dose study (100 mg CoQ10, several different formulations) on healthy young participants (18-33 years), where a ubiquinone formulation was notably more bioavailable than ubiquinol [29].…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, in a single-dose (100 mg) study on older participants (>60 years), Evans et al [19] reported more distinct differences between the bioavailabilities of ubiquinol and ubiquinone formulations; however, they did not test water-soluble CoQ10 formulations. On the other hand, López-Lluch et al have recently reported the results of their single-dose study (100 mg CoQ10, several different formulations) on healthy young participants (18-33 years), where a ubiquinone formulation was notably more bioavailable than ubiquinol [29].…”
Section: Discussionmentioning
confidence: 99%
“…Another limitation of our study was that there is no negative control, i.e., meals alone. In the previous reports, there was no placebo control for the determination of the absorption/bioavailability of CoQ 10 supplements [25][26][27][52][53][54][55]. Also, the effect of CoQ 10 contents in the provided meals seemed to be extremely low as the estimated CoQ 10 amount was less than one two-hundredth of the CoQ 10 supplements ingested.…”
Section: Discussionmentioning
confidence: 98%
“…Secondly, mitochondrial inefficiency could be targeted during synaptogenesis in affected children using a variety of relatively safe therapeutic agents, such as CoQ 10 80 . Although CoQ 10 has low bioavailability and must be administered in high doses to achieve brain penetration, such an agent could be seamlessly incorporated into future multimodal therapeutic approaches to treat FXS 81,82 …”
Section: Discussionmentioning
confidence: 99%